IPAB repeal to be tied to malpractice legislation

House Republicans plan to tie the repeal of the Independent Payment Advisory Board to medical malpractice legislation when Congress resumes next week.

The bill to repeal IPAB, H.R. 452, passed both the House Energy and Commerce and Ways and Means committees last week.

Repealing the board is expected to cost the federal government $3 billion, and Republicans plan to offset this cost by tying it to a bill that limits damages for medical malpractice cases. H.R. 5's provisions include a $250,000 cap on noneconomic damages, establishing a time limit on malpractice claims and putting a limit on attorney contingency fees. The CBO said H.R. 5 would reduce healthcare spending by around 0.4%, and the federal deficit by around $40 billion. This would occur through lowered premiums for medical liability insurance and reducing the use of healthcare services prescribed by providers worried about being sued. These reductions would lead to lower spending by federal health programs, the CBO wrote last year.

Neither bill is expected to gain traction in the Democrat-controlled Senate; the tie to malpractice legislation likely means the loss of Democratic support, The Hill reported.

The Congressional Budget Office estimated last year that repealing IPAB would cost $3.1 billion over 10 years, although it said that Medicare spending has been slowing and the IPAB probably wouldn't have to recommend payment changes until 2022.

More in News

Government agency launches health IT webpage for long-term care providers

Government agency launches health IT webpage for long-term ...

The Office of the National Coordinator for Health Information Technology has unveiled a new webpage with information and resources for long-term and post-acute (LTPAC) providers.

FDA responds to provider pressure, backs off stricter control of fecal transplants ...

Individuals with treatment-resistant Clostridium difficile can undergo fecal transplants after giving informed consent, the Food and Drug Administration recently announced. This is a victory for providers, who pushed back after the FDA recently announced it would tighten regulations around the transplants.

Judge denies Omnicare's 'untimely' motion to disqualify whistleblower in nursing home kickbacks ...

Omnicare has failed to disqualify a whistleblower who alleges the long-term care pharmacy paid kickbacks to nursing homes, ruled a district court judge.